ADCETRIS
NDC 51144-050, brentuximab vedotin, injection, powder, lyophilized, for solution, from SEAGEN INC..
- Product NDC
- 51144-050
- Status
- Listed
- Labeler
- SEAGEN INC.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125388
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51144-050 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BRENTUXIMAB VEDOTIN50 mg/10.5mL
Pharmacologic classes
CD30-directed Antibody Interactions [MoA]; CD30-directed Immunoconjugate [EPC]; Immunoconjugates [CS]; Microtubule Inhibition [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51144-050-01 | 51144005001 | 1 VIAL, SINGLE-DOSE in 1 BOX (51144-050-01) / 10.5 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3904f8dd-1aef-3490-e48f-bd55f32ed67fMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=51144-050
Use it
Look up 51144-050 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51144-050 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51144-050. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.